Suchergebnisse - "Cecere, Fabiana Letizia"

PubPharm (36)

1

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Leonetti, A. | Perrone, F. | Puntoni, M. | +43

2

Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?

enthalten in: Surgery today | 2024

von Gallina, F. | Cecere, F. | Tajè, R. | +4

3

Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC : A systematic review and meta-analysis of randomised clinical trials

enthalten in: Critical reviews in oncology/hematology | 2023

von Marinelli, D. | Gallina, F. | Pannunzio, S. | +23

4

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2023

von Chu, Q. | Perrone, F. | Greillier, L. | +32

CommentIn: Lancet. 2023 Dec 16;402(10419):2266-2267. - PMID 37931626

5

The Molecular Tumor Board of the Regina Elena National Cancer Institute : from accrual to treatment in real-world

enthalten in: Journal of translational medicine | 2023

von Giacomini, P. | Valenti, F. | Allegretti, M. | +30

6

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

enthalten in: Journal of translational medicine | 2023

von Giacomini, P. | Valenti, F. | Allegretti, M. | +30

7

Brief Report : Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Piccirillo, M. | Chu, Q. | Bradbury, P. | +32

CommentIn: J Thorac Oncol. 2023 Jun;18(6):e67-e68. - PMID 37210188

8

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC

enthalten in: Frontiers in oncology | 2023

von Gallina, F. | Marinelli, D. | Tajè, R. | +10

9

Not enough can be enough : feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available

enthalten in: Journal of clinical pathology | 2022

von Ercolani, C. | Di Benedetto, A. | Bonomo, C. | +10

10

A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC : Implications for Targeted Therapies in the Adjuvant Setting

enthalten in: Cancers | 2022

von Terrenato, I. | Ercolani, C. | Di Benedetto, A. | +15